Prosecution Insights
Last updated: May 29, 2026
Application No. 17/063,637

Droplet-Generating Microfluidic Chips and Related Methods

Non-Final OA §102§103
Filed
Oct 05, 2020
Priority
Oct 22, 2018 — provisional 62/748,919 +3 more
Examiner
HYUN, PAUL SANG HWA
Art Unit
1796
Tech Center
1700 — Chemical & Materials Engineering
Assignee
Pattern Bioscience Inc.
OA Round
7 (Non-Final)
70%
Grant Probability
Favorable
7-8
OA Rounds
0m
Est. Remaining
99%
With Interview

Examiner Intelligence

Grants 70% — above average
70%
Career Allowance Rate
583 granted / 837 resolved
+4.7% vs TC avg
Strong +36% interview lift
Without
With
+36.4%
Interview Lift
resolved cases with interview
Typical timeline
3y 5m
Avg Prosecution
32 currently pending
Career history
879
Total Applications
across all art units

Statute-Specific Performance

§101
0.2%
-39.8% vs TC avg
§103
71.7%
+31.7% vs TC avg
§102
7.9%
-32.1% vs TC avg
§112
18.1%
-21.9% vs TC avg
Black line = Tech Center average estimate • Based on career data from 837 resolved cases

Office Action

§102 §103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Continued Examination Under 37 CFR 1.114 A request for continued examination under 37 CFR 1.114, including the fee set forth in 37 CFR 1.17(e), was filed in this application after final rejection. Since this application is eligible for continued examination under 37 CFR 1.114, and the fee set forth in 37 CFR 1.17(e) has been timely paid, the finality of the previous Office action has been withdrawn pursuant to 37 CFR 1.114. Applicant's submission filed on April 30, 2026 has been entered. Claims 1-20 remain pending. Applicant amended independent claims 1 and 11. Response to Arguments The amendment necessitated the new ground of rejection set forth below, rendering moot Applicant’s remarks. While the new ground of rejection is still based on the disclosure of Arab, the rejection includes different mapping of the claim language to the disclosure of Arab. Claim Rejections - 35 USC § 102 Claims 1, 7, 8, 10, 11, 17, 18 and 20 are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Arab (US 2016/0271576 A1). With respect to claim 1, Arab discloses a microfluidic chip (see [0007]) comprising a microfluidic network that includes (see Fig. 2): 1) an inlet port (left end of channel 107); 2) a channel 107 configured to receive liquid from the inlet port; and 3) a droplet-generating region including: b) a constant portion 101 extending from an outlet (location corresponding to step 110) of the channel 107 having a transverse dimension (CH), the constant portion 101 having: i) a length (T1); and ii) a constant transverse dimension (SH1) along the length of the constant portion, measured parallel to the transverse dimension (CH) of the outlet of the channel, that is larger than the transverse dimension (CH) of the outlet of the channel; and c) an expanding portion 102/103 extending from the constant portion 101, the expanding portion having: i) a length T2/T3; and ii) a transverse dimension (height), measured parallel to the transverse dimension (SH1) of the constant portion, that increases along the length of the expanding portion, from a first value (SH2) that is greater than the transverse dimension (SH1) of the constant portion 101 to a second value (SH3) that is greater than the first value (SH2); wherein the transverse dimension (CH) of the outlet of the channel, the length (T1) of the constant portion, and the transverse dimension (SH1) of the constant portion are configured such that, when an aqueous liquid is flowed through the droplet-generating region in the presence of a non-aqueous liquid (see [0070]), the aqueous liquid must flow through the outlet of the channel 107 to enter the constant portion 101 (see direction of flow illustrated in Fig. 3A), and wherein no portion of droplets of the aqueous liquid forms in the channel 107 (see Fig. 3A). With respect to claim 11, Arab also discloses a method of loading a microfluidic chip, the method comprising (see Figs. 3A-3C): forming droplets of an aqueous liquid 151 (see [0070]) by flowing the aqueous liquid 151 through the channel 107 and through the droplet-generating region in the presence of a non-aqueous liquid (see [0070] and Figs. 3A-3C), wherein no portion of droplets of the aqueous liquid 151 forms in the channel 107 (see Fig. 3A). Regarding the limitations directed to the structure of the chip, refer to the rejection of claim 1. With respect to claims 7, 8, 17 and 18, Arab discloses an embodiment in which the ratio of SH1 to CH is 1.5 (see [0010]). With respect to claims 10 and 20, the expanding portion includes a first step 112 along which the expanding portion has the first transverse dimension (SH2), and a second step 113 along which the expanding portion has the second transverse dimension (SH3) (see Fig. 2). Claim Rejections - 35 USC § 103 The text of those sections of Title 35, U.S. Code not included in this action can be found in a prior Office action. Claims 2-5 and 12-15 are rejected under 35 U.S.C. 103 as being unpatentable over Arab. With respect to claims 2-4 and 12-14, Arab discloses that the value of CH (see Fig. 2) can range between 1 and 50 microns (see [0013]), meaning it would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to have provided the transverse dimension (CH) of the outlet of the channel with a value (e.g. 10 microns, 20 microns) that falls within the ranges recited in claims 2-4 and 12-14. Regarding the length (T1) of the constant portion, Arab further discloses that the ratio of T1 to CH is between 0.1 and 7 (see [0012]), meaning the range of the length (T1) of the constant portion taught by Arab falls outside of the claimed ranges. Nevertheless, Arab discloses that the value of T1 is chosen to ensure proper separation between adjacent droplets formed by the device (see [0073]). Based on the diameter/length of the droplets produced by the device (which is determined by many variables, see [0064]), it would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to have provided the length (T1) of the constant portion with a value that is at least 10x the value of CH. A high T1 to CH ratio would ensure adequate separation between adjacent droplets. If the modification is made, then the length (T1) of the constant portion would have a value that falls within the claimed ranges. With respect to claims 5 and 15, as discussed above, the ratio of T1 to CH is between 0.1 and 7 (see [0012]). Based on the disclosure, it would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to have provided the length (T1) of the constant portion and the transverse dimension (CH) of the outlet of the channel such that the ratio of T1 to CH is at least 7.5 (The ratio of “7” taught by Arab is deemed to encompass/render obvious ratio of 7.5). With respect to claims 6 and 16, the ratio of T1 to CH is between 0.1 and 7 (see [0012]), which does not overlap the claimed range of at least 10. However, as discussed above (see rejection of claims 2-4 and 12-14), it would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to have provided the length (T1) of the constant portion with a value that is at least 10x the value of CH. A high T1 to CH ratio would ensure adequate separation between adjacent droplets. With respect to claims 9 and 19, Arab discloses an embodiment in which the ratio of SH1 to CH is 1.5 (see [0010]). Moreover, as discussed above (see rejection of claims 2-4, 6, 12-14 and 16), it would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to have provided the length (T1) of the constant portion that is at least 10x the value of CH. A high T1 to CH ratio would ensure adequate separation between adjacent droplets. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to PAUL S HYUN whose telephone number is (571)272-8559. The examiner can normally be reached M-F 8:30-5:00. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Luan Van can be reached at 571-272-8521. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /PAUL S HYUN/Primary Examiner, Art Unit 1796
Read full office action

Prosecution Timeline

Show 10 earlier events
Apr 14, 2025
Response after Non-Final Action
Apr 23, 2025
Final Rejection mailed — §102, §103
Oct 23, 2025
Request for Continued Examination
Oct 27, 2025
Response after Non-Final Action
Oct 30, 2025
Final Rejection mailed — §102, §103
Apr 30, 2026
Request for Continued Examination
May 01, 2026
Response after Non-Final Action
May 08, 2026
Non-Final Rejection mailed — §102, §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12638466
AUTOMATIC ANALYZER
5y 2m to grant Granted May 26, 2026
Patent 12636645
MICROFLUIDIC DEVICES
3y 8m to grant Granted May 26, 2026
Patent 12623225
SYSTEM AND METHOD FOR RECEIVING AND DELIVERING A FLUID FOR SAMPLE PROCESSING
3y 6m to grant Granted May 12, 2026
Patent 12616243
E-VAPING CARTRIDGE
5y 8m to grant Granted May 05, 2026
Patent 12605715
MAGNETIC STAND
3y 4m to grant Granted Apr 21, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

7-8
Expected OA Rounds
70%
Grant Probability
99%
With Interview (+36.4%)
3y 5m (~0m remaining)
Median Time to Grant
High
PTA Risk
Based on 837 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month